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ABSTRACT Since the late 1990s, changes in the epidemiology of methicillin-
resistant Staphylococcus aureus (MRSA) were recognized with the emergence of
community-associated MRSA (CA-MRSA). CA-MRSA belonging to clonal complex 152
(CC152), carrying the small staphylococcal cassette chromosome mec (SCCmec) type
V and encoding the Panton-Valentine leukocidin (PVL), has been observed in Europe.
The aim of this study was to investigate its origin, evolution, and dissemination.
Whole-genome sequencing was performed on a global collection of 149 CC152 iso-
lates spanning 20 years (93 methicillin-susceptible S. aureus [MSSA] and 56 MRSA
isolates). Core genome phylogeny, Bayesian inference, in silico resistance analyses,
and genomic characterization were applied. Phylogenetic analysis revealed two ma-
jor distinct clades, one dominated by MSSA and the other populated only by MRSA.
The MSSA isolates were predominately from sub-Saharan Africa, whereas MRSA was
almost exclusively from Europe. The European MRSA isolates all harbored an SCCmec
type V (5C2&5) element, whereas other SCCmec elements were sporadically detected
in MRSA from the otherwise MSSA-dominated clade, including SCCmec types IV (2B),
V (5C2), and XIII (9A). In total, 93% of the studied CC152 isolates were PVL positive.
Bayesian coalescent inference suggests an emergence of the European CC152-MRSA
in the 1990s, while the CC152 lineage dates back to the 1970s. The CA-MRSA CC152
clone mimics the European CC80 CA-MRSA lineage by its emergence from a PVL-
positive MSSA ancestor from North Africa or Europe. The CC152 lineage has ac-
quired SCCmec several times, but acquisition of SCCmec type V (5C2&5) seems asso-
ciated with expansion of MRSA CC152 in Europe.
IMPORTANCE Understanding the evolution of CA-MRSA is important in light of the
increasing importance of this reservoir in the dissemination of MRSA. Here, we high-
light the story of the CA-MRSA CC152 lineage using whole-genome sequencing on
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an international collection of CC152. We show that the evolution of this lineage is
novel and that antibiotic usage may have the potential to select for the phage-
encoded Panton-Valentine leukocidin. The diversity of the strains correlated highly
to geography, with higher level of resistance observed among the European MRSA
isolates. The mobility of the SCCmec element is mandatory for the emergence of
novel MRSA lineages, and we show here distinct acquisitions, one of which is linked
to the successful clone found throughout Europe today.
KEYWORDS CA-MRSA, CC152, MRSA, PVL, SCCmec, antibiotic resistance, evolution,
genetics, virulence, S. aureus
In the late 1990s, a remarkable change in the epidemiology of Staphylococcus aureuswas observed with the emergence of methicillin-resistant S. aureus (MRSA) in the
community (1, 2). Today, multiple lineages of community-associated MRSA (CA-MRSA)
are observed worldwide (3), and the evolutionary history of some of these has been
described in detail using whole-genome sequencing on global collections of isolates
(4–7). As common characteristics, CA-MRSA clones generally are less resistant to
antibiotics than health care-associated MRSA (HA-MRSA), harbor smaller staphylococcal
cassette chromosome mec (SCCmec) type IV or V elements, and often express the
Panton-Valentine leukocidin (PVL) toxin encoded by the prophage genes lukS/F-PV.
However, the clinical epidemiological distinction between HA- and CA-MRSA has
started to dissipate as CA-MRSA lineages, in particular USA300, have expanded their
niches into hospitals (8, 9). CA-MRSA clones have been observed to be geographically
restricted (10), with the European CA-MRSA as one example. This lineage, belonging to
clonal complex 80 (CC80), was derived from a PVL-positive methicillin-susceptible S.
aureus (MSSA) ancestor from sub-Saharan Africa and became a dominant CA-MRSA
clone in Europe, Northern Africa, and the Middle East in the 1990s and 2000s (5). Other
well-characterized CA-MRSA lineages that also have shown intercontinental transmis-
sion include USA300, where genome analyses point to a European ancestor prior to
acquisition of PVL and SCCmec type IV in the United States (6), and the multidrug-
resistant and PVL-positive Bengal Bay clone (MLST sequence type 772 [ST772]) that has
spread globally with an origin in community- and health care-associated environments
in India (4).
The different CA-MRSA lineages observed worldwide have shown different geo-
graphical origins and dissemination patterns and with key genetic acquisitions strongly
associated with their expansion. The S. aureus lineage CC152 has been linked to
community cases throughout Europe and in particular with strong epidemiological
links to the Balkan region and encodes key CA-MRSA genetic features such as PVL and
carriage of a small SCCmec type V element (3, 11). CC152 PVL-positive MSSA isolates
have been reported in the Canary Islands and in sub-Saharan Africa and was found as
a highly dominant nasal carrier clone in Mali (11). In the present study, an international
collection of CC152 MSSA and MRSA isolates was investigated to understand the origin,
evolution, and dissemination of the lineage.
RESULTS
Strain collection and genome sequencing. This study included 149 CC152 S.
aureus isolates (93 MSSA and 56 MRSA) sampled between 1999 to 2015 in 28 different
countries in Europe, Africa, Australia, and the Caribbean Islands (Fig. 1; see also Table S1
in the supplemental material). Of these, 31 were selected and obtained for genome
sequencing based on the MRSA TypeCat database to expand the temporal and
geographical diversity of the collection and 10 genomes were obtained from NCBI’s
RefSeq database.
The majority of the CC152 isolates belonged to ST152 (n 139; 93%); of the
remaining 10 isolates (seven MSSA and three MRSA), 9 were single-locus variants of
ST152 (four ST1518, one ST1831, and four different new STs), whereas another single
isolate was a double-locus variant of ST152 (new ST; see Table S1). Twenty-two different
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spa types were identified, with t355 being the most common (n 98; 65.8%; see
Table S1). The isolates were sequenced to an average depth of 120-fold.
Phylogenetic relatedness and geography. A total of 5,189 single nucleotide
polymorphisms (SNPs) was detected within 82% (2.19 Mb) of the detected CC152
core genome among all 149 isolates. Five different strains, which were used for rooting
the tree, all revealed identical rooting and overall topology (data not shown). The
rooted phylogeny was based on 5,149 SNPs after purging of eight putative recombi-
1999     2000      2001      2002      2003      2004     2005      2006      2007      2008     2009      2010      2011     2012      2013     2014     2015
A)
B)
One isolate
27 isolates
FIG 1 Geographical and temporal distribution of S. aureus CC152 isolates. Black and red dots indicate MSSA (n 93) and MRSA (n 56) isolates, respectively.
(A) Geographical distribution of the CC152 isolates from 28 different countries in Europe, Africa, Australia, and the Caribbean. The dots are scaled according
to the prevalence as indicated. (B) Timeline showing the sampling years of the isolates (1999 to 2015).
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nant regions spanning between three and 15 nucleotides (see Fig. S1 in the supple-
mental material). An unrooted CC152 phylogeny (Fig. 2A) showed mainly two distinct
clades, one contained primarily MSSA isolates (MSSA-dominated clade, Fig. 2A), and the
other contained only MRSA isolates (MRSA clade, Fig. 2A). By rooting the phylogeny
(Fig. 2B) and population with geographical data, the MRSA clade was linked almost
exclusively to Europe, while the other more diverse clade contained mainly isolates
from sub-Saharan Africa and the Caribbean but also some with a European origin. All
major clades had high posterior bootstrap values (Fig. S3).
SCCmec acquisition and diversity. The MRSA clade contained the majority of
MRSA isolates (53/56, 95%), which all carried SCCmec type V (5C2&5), indicating a single
acquisition of the SCCmec element (Fig. 2A). Four isolates had a deletion of a smaller
region containing the ccrC1 gene. The remaining three MRSA isolates (55-99-35,
55-99-40, and 55-99-44) in the collection were unrelated and clustered in the MSSA-
dominated clade. These isolates carried three different SCCmec elements: a type V
(5C2), a type IV (2B), and a type XIII (9A).
Prevalence of the Panton-Valentine leukocidin-encoding Sa2 prophage.
Among the CC152 isolates, the majority (n 139, 93%,) were PVL positive and carried
lukF/S-PV genes in the Sa2 prophage. Sequence analysis of the diversity of the Sa2
PVL-prophage (Fig. S2) among CC152 and other Sa2 positive CA-MRSA lineages clearly
support a single ancestral acquisition of the Sa2 prophage in CC152. The PVL-negative
isolates (n 10) were generally scattered across the tree, indicating independent loss
of the prophage (Fig. 2).
Coalescent analysis of CC152. The best model for the Bayesian analysis was the
general time reversible (GTR) model under the random local clock and the Bayesian
Skyline prior with a10 Bayes factor. The analysis revealed that the time to most recent
common ancestor (TMRCA) of the CC152 lineage dated to 1970 (95% highest
posterior densities [HPDs], 1964 to 1974), and with the emergence of the MRSA clade
25 years later (95% HPDs, 1993 to 1995) based on the included strain collection. The
time tree shared a highly similar tree topology (Fig. 2B) with the rooted maximum-
likelihood phylogeny (Fig. S1). The Skyline plot (Fig. S4) shows a large increase in
effective population size coinciding with the acquisition of the SCCmec element in the
monophyletic MRSA clade. The time-based tree (Fig. 2B) further supports the hypoth-
esis that the ancestral population of CC152 was PVL positive. All MRSA isolates were
from Europe except for one isolate from Australia, regardless of the position in the
phylogeny (Fig. 2A). The majority of the MSSA isolates formed a large clade of isolates
from Europe, sub-Saharan Africa, and the Caribbean. Six MSSA isolates (intermittent
group, Fig. 2A) clustered between the MSSA-dominated clade and the MRSA clade with
four from Europe and two from North Africa. Combined, the analyses point to an origin
of CC152 lineage in North Africa or in Europe.
Resistance determinants and genetic context. Among the 149 isolates, 14 differ-
ent resistance genes were detected (Table 1 and Fig. S1). The predominant resistance
determinant among the 149 CC152 isolates was blaZ (n 137, 92%), whereas the
aminoglycoside resistance gene aac(6=)-aph(2) was almost exclusively found in the
MRSA clade (n 51, 96%) but rarely found outside this clade (n 2, 2%). Analysis of
the predominant SCCmec type V (5C&5C2) showed the aac(6=)-aph(2) gene to be part
of the J2 region of the element in 93% of these isolates, including all isolates in the
MRSA clade. The aminoglycoside resistance gene aadD was only found in 19% of
isolates (n 10/96) in the MRSA clade. However, dfrG conferring resistance to trim-
ethoprim was found in 19% (n 18/96) of the MSSA isolates found to reside in two
distinct monophyletic groups: one included 10 isolates where dfrG resided in the
PVL-encoding prophage Sa2, whereas in the other monophyletic group of 8 isolates
no prophage or other identifiable genetic element was identified in the vicinity of the
resistance gene (data not shown). No isolates carried known fusA mutations, and only
a single MRSA isolates carried the fusB gene linked to fusidic acid resistance. Carriage
of the tetracycline resistance determinant tet(K) was found throughout the phylogeny,
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FIG 2 Temporal and geographical relatedness of the S. aureus CC152 lineage. The phylogenies are based on 5,149 SNPs
identified in 82% of the reference chromosome. (A) Unrooted phylogeny of the 149 CC152 isolates. (B) Time-based tree of the
149 CC152 isolates. The black and red branches indicate the MSSA and MRSA isolates, respectively. All isolates are PVL positive
except when blue dots are present. The colors in the outer ring represent the continental origins of the isolates as follows:
Australia (yellow), Caribbean (brown), Europe (green), North Africa (purple), and sub-Saharan Africa (blue).
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with 19% (n 10/49) of the isolates positive in the MRSA clade and 29% (n 28/96)
among the remaining isolates, all located on a pT181 plasmid.
DISCUSSION
The S. aureus CC152 lineage has been reported as a PVL-positive CA-MRSA that has
only rarely been reported outside the European continent. Conversely, PVL-positive
CC152 MSSA isolates have been associated with the African continent and the Carib-
bean and less often in Europe (8, 11). Thus, the evolution of CC152 resembles in many
ways the genotypic and spatial characteristics of the European CC80 CA-MRSA clone (5).
Here, we analyzed a collection covering 28 countries and spanning from the earliest
reported isolates in 1999 until 2015 to understand the evolution of the CC152 lineage.
The data in this study, combining molecular analyses in conjunction with temporal
and spatial information, indicate that the CA-MRSA CC152 clone originated north of the
Sahara from a PVL-positive MSSA ancestor. Using both phylogenetic approaches with
the available data, deep branches near the root all point to European or Northern
African MSSA isolates. Specifically, a small cluster of three isolates, including two North
African (Algerian) and a single European (French) isolate, clustered ancestral to the
monophyletic European MRSA clade (Fig. 2B). However, since no epidemiological
information about these three isolates were available and there is a cultural and
geographical proximity between France and Northern Africa, our data do not allow us
to infer the precise geographical origin of the MRSA ancestor. The other major clade
identified in the phylogeny contained mostly MSSA isolates of sub-Saharan African and
Caribbean isolates. Ruimy et al. proposed that, similarly to the European CC80 CA-MRSA
clone, the CC152 lineage originated in sub-Saharan Africa and spread to Europe and
subsequently acquired the SCCmec element (11). However, the results of our genome-
based analyses do not support such a sub-Saharan origin.
Multiple CA-MRSA lineages emerged globally in the 1990s and are generally pre-
dominantly found in specific geographical regions (10) exemplified by the European
CA-MRSA CC80 clone, USA300 (5, 6, 12), and now the CC152 CA-MRSA clone. In both
the ST8 and the CC80 lineages, SCCmec elements were acquired on multiple occasions
(6, 13, 14); however, successful clones, including both the North and South American
variants of USA300 and the European CA-MRSA, are all associated with single acquisi-
tions of an SCCmec element. A similar pattern is observed for the CC152 lineage, where
multiple acquisitions of distinct SCCmec elements, including an SCCmec element type
XIII (15), are evident, but only the acquisition of SCCmec type V (5C2&5) is associated
with its expansion in Europe. Another key characteristic of the CA-MRSA lineages is the
presence of PVL-encoding genes; both CC80 and CC152 have ancestral PVL acquisi-
tions, whereas the CC8 lineage has an ancestral PVL-negative population (5, 6, 11). The
TABLE 1 Overview of different resistance genes, showing the antibiotic class and number of isolates for each resistance gene according
to the phylogenetic clustering
Resistance gene Antibiotic class
No. (%) of isolates
MRSA clade (n 53) MSSA-dominated clade (n 96)
tet(K) Tetracycline 10 (19) 28 (29)
cat(pC233) Phenicol 6 (11) 0
cat(pC221) Phenicol 1 (2) 5 (5)
blaZ Beta-lactam 49 (92) 88 (92)
mecA, SCCmec type Beta-lactam 53 (100), V(5C2&5)a 3 (3), IV, V(5C2), XIII
aac(6=)-aph(2) Aminoglycoside 2 (2) 51 (96)
aadD Aminoglycoside 0 10 (19)
aph(3=)-III Aminoglycoside 1 (1) 0
str Aminoglycoside 3 (3) 0
dfrG Trimethoprim 18 (19) 0
fusB Fusidic acid 1 (1) 0
msr(A) Macrolide, lincosamide, streptogramin B 1 (1) 0
lnu(A) Macrolide, lincosamide, streptogramin B 0 8 (15)
erm(C) Macrolide, lincosamide, streptogramin B 2 (2) 2 (4)
aFour isolates only had one ccrC1 gene equivalent to an SCCmec type V(5C2).
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finding here of dfrG, a determinant for trimethoprim resistance, in the Sa2 prophage
is interesting since trimethoprim resistance is common in S. aureus from sub-Saharan
Africa. This has previously been linked to the prophylactic use of trimethoprim in
HIV-infected persons (16, 17), and thus trimethoprim may select for carriage of such
PVL-positive isolates.
In general, CA-MRSA has been categorized as carrying fewer resistance genes compared
to HA-MRSA (18); however, the CC152 MRSA isolates in addition to mecA and blaZ also
harbor an aminoglycoside resistance gene [aac(6=)-aph(2)] found to reside in the SCCmec
element for 95% (53/56) of the MRSA isolates. Since aminoglycoside antibiotics are mainly
used in hospitals, (19), this may explain why the CC152 MRSA clone spread and thrived in
hospitals, as well as in the community (20). Overall, a greater number of resistance genes
was observed among the MRSA than among MSSA isolates, but this could be the result of
sampling bias. Interestingly, only a single MRSA isolate was genotypically resistant to fusidic
acid due to the carriage of fusB, and investigations into resistance-related mutations in fusA
showed the absence of any such variants. This is striking compared to the prevalence and
speculated importance of fusidic acid resistance observed in the European CC80 CA-MRSA
clone (5).
Of the sub-Saharan cases with epidemiological data, 15% of the CC152 MSSA
isolates were reported from bacteremia cases, which likely reflects its high prevalence
as a carrier clone in sub-Saharan Africa rather than being an indication of increased
virulence potential. The results of this study show an overall low level of resistance,
restricted geographical spread, the harboring of smaller SCCmec elements, and carriage
of genes encoding PVL in CC152 and hence a resemblance to other CA-MRSA clones.
In conclusion, we demonstrate that multiple SCCmec acquisitions have occurred in
the CC152 lineage; however, only one is linked to the successful clone now found
throughout Europe. Our analyses support a unique evolutionary path of this PVL-
positive clone that most likely indicates a European or North African ancestral origin
with the emergence of the CA-MRSA clone around the 1990s, similar to findings for
other investigated CA-MRSA lineages.
MATERIALS AND METHODS
Bacterial isolates. A total of 149 S. aureus CC152 isolates, including 93 MSSA and 56 MRSA isolates,
sampled in Australia (n 1), the Caribbean (n 24), Europe (n 73), northern Africa (n 2), and
sub-Saharan Africa (n 49) between 1999 and 2015 were included in this study. To obtain representative
temporal and spatial collection of CC152 genomes, isolates and publicly available genomic data were
selected and obtained from national reference collections, NCBI’s Reference Sequence Database (https://
www.ncbi.nlm.nih.gov/refseq/) and the MRSA TypeCat database (21) that contains a systematic review of
S. aureus in all indexed literature with information on genotypic data published between 2000 and 2015
(see Table S1). Microreact (https://microreact.org) v5.112.3 was used to visualize the geographical and
temporal distribution of the CC152 isolates (Fig. 1).
Ethics. All isolates and epidemiological information were obtained either based on previously
published work or by local regulations that allow use for research.
Genome sequencing. In this study, we performed whole-genome sequencing on 139 CC152 isolates
using a Nextera XT DNA Library Prep kit (Illumina) generated libraries to obtain pair-end data on
Illumina’s NextSeq and MiSeq platforms with 300- or 500-cycle kits. All generated sequence reads are
deposited at the European Nucleotide Archive (ENA; https://www.ebi.ac.uk/ena) under study accession
no. PRJEB36544. The remaining 10 genomes were downloaded from the NCBI (Table S1).
Phylogenetic analysis. SNPs were detected in the core genome using the Northern Arizona SNP
pipeline (NASP [22]) by aligning Illumina reads against the 2.67-Mbp chromosome of S. aureus ST152
MSSA strain SA17_S6 (GenBank accession number CP010941). Positions with a 10-fold sequencing
depth and/or 90% unambiguous base calls were removed. Putative signs of recombination, defined as
if more than three consecutive SNPs in individual or clusters of isolates were observed in the resulting
SNP matrix, were removed as previously described (5). Relatedness was investigated using the maximum-
likelihood algorithm as implemented in PhyML v3.0 (23, 24), using smart model selection with the
Bayesian information criterion with 100 bootstrap replicates and with subtree-pruning and -grafting
rearrangements for improved tree structures. For rooting, the chromosome of five unrelated S. aureus
strains belonging to ST8, ST30, ST45, ST80, and ST398 (GenBank accession numbers CP000730, BX571856,
NC_021554, CP003194, and AM990992, respectively) were used individually. The phylogenetic trees were
visualized using iTOL v4.2.3 (25).
Coalescent analyses. Bayesian analyses were used to investigate the TMRCA method using BEAST
v1.8.4 (26). BEAST was performed using the GTR and Hasegawa-Kishino-Yano (HKY) substitution models
combined with both strict and random local clock under different coalescent tree priors (Bayesian
Skyline, constant population, and exponential growth). Evaluation of the model combinations was
Evolution and Origin of a European CA-MRSA Clone
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performed by Tracer v1.7.1 (http://tree.bio.ed.ac.uk/software/tracer/) using Bayes factor (27). All Markov
chain Monte Carlo analyses were run twice with chain lengths of 200 million with sampling every
20,000th generation and using a burn-in set at 10%. A time tree was obtained using the maximum sum
clade credibility topology with TreeAnnotator v2.5.2 from the BEAST package and visualized using iTOL.
Genetic typing. Whole-genome sequences were de novo assembled using SPAdes v3.13.1 (28).
Assemblies were used for in silico multilocus sequence typing (MLST) (28, 29) passed through spaTyper
v1.0 (30), ResFinder v2.1 (31), and SCCmecFinder v1. (32) for the determination of spa types, resistance
genes, and SCCmec characterization, respectively, at the Center for Genomic Epidemiology (https://cge
.cbs.dtu.dk). Furthermore, CLCbio’s Genomics Workbench v9 (Qiagen, Aarhus, Denmark) was used for
additional investigations of resistance genes and SCCmec characterization. Similarly, detection of point
mutations related to fusidic acid resistance was performed using BLASTN searches across the collection
using fusA extracted from the ST152 reference genome (GenBank accession no. CP010941). The draft
genomes were analyzed for the presence of PVL-encoding genes lukF/S-PV and for intradiversity of the
associated Sa2 prophage within the CC152 collection and other S. aureus clonal lineages. The full-length
Sa2 prophage in the ST152 reference was identified using the PHAge Search Tool Enhanced Release
(PHASTER) tool (http://phaster.ca/). The identified Sa2 prophage in ST152 reference genome was used
as reference in a SNP-based analysis, including all PVL-positive CC152 isolates together with genomes of
other CA-MRSA PVL-positive lineages (CC1, CC8, CC30, CC59, CC80, and CC93; GenBank accession no.
NC_003923, CP000730, CP002110, NC_016928, NC_017351, and CP002114, respectively). The SNP align-
ment of the prophage was purged for putative recombination, and a phylogeny was constructed with
PhyML v3.0 as previously described.
Data availability. All generated sequence reads are deposited at the ENA (https://www.ebi.ac.uk/
ena) under study accession no. PRJEB36544.
SUPPLEMENTAL MATERIAL
Supplemental material is available online only.
FIG S1, EPS file, 2.7 MB.
FIG S2, EPS file, 1.3 MB.
FIG S3, EPS file, 2.6 MB.
FIG S4, EPS file, 2.9 MB.
TABLE S1, XLSX file, 0.02 MB.
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